Analyst Research

Report Title Price
Provider: Wright Reports
Provider: Thomson Reuters Stock Report
Provider: MacroRisk Analytics/EconomicInvestor
Provider: Sadif Analytics Prime

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Tianyin Pharmaceutical Co Inc Reiterates FY 2013 Revenue Guidance

Thursday, 14 Feb 2013 05:55am EST 

Tianyin Pharmaceutical Co Inc reiterated its fiscal 2013 revenue projection of approximately $75 million to $80 million. 

Company Quote

0.2023 +39.67%
26 Dec 2014